questionsmedicales.fr
Composés chimiques organiques
Radicaux libres
Peroxydes
2-Hydroperoxy-2-méthyl-propane
2-Hydroperoxy-2-méthyl-propane : Questions médicales fréquentes
Diagnostic
5
Exposition professionnelle
Tests de laboratoire
Marqueurs biologiques
Enzymes hépatiques
Effets à long terme
Évaluations fonctionnelles
Symptômes
5
Irritation
Symptômes aigus
Symptômes neurologiques
Maux de tête
Réaction allergique
Éruptions cutanées
Voies respiratoires
Essoufflement
Prévention
5
Prévention
Équipements de protection
Formations
Produits chimiques
Déversements
Procédures d'urgence
Ventilation
Zones de travail
Traitements
5
Intoxication
Soins symptomatiques
Antidotes
Traitement symptomatique
Brûlures cutanées
Traitement
Suivi médical
Effets à long terme
Soins d'urgence
Symptômes graves
Complications
5
Complications
Exposition prolongée
Effets sur la reproduction
Études
Troubles respiratoires
Exposition aiguë
Facteurs de risque
5
Travailleurs
Industrie chimique
Antécédents médicaux
Maladies hépatiques
Femmes enceintes
Vulnérabilité
Conditions environnementales
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "2-Hydroperoxy-2-méthyl-propane : Questions médicales les plus fréquentes",
"headline": "2-Hydroperoxy-2-méthyl-propane : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les 2-Hydroperoxy-2-méthyl-propane : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-09",
"dateModified": "2026-06-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "2-Hydroperoxy-2-méthyl-propane"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Peroxydes",
"url": "https://questionsmedicales.fr/mesh/D010545",
"about": {
"@type": "MedicalCondition",
"name": "Peroxydes",
"code": {
"@type": "MedicalCode",
"code": "D010545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.389.338"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "2-Hydroperoxy-2-méthyl-propane",
"alternateName": "tert-Butylhydroperoxide",
"code": {
"@type": "MedicalCode",
"code": "D020122",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michiko Matsuse",
"url": "https://questionsmedicales.fr/author/Michiko%20Matsuse",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University."
}
},
{
"@type": "Person",
"name": "Norisato Mitsutake",
"url": "https://questionsmedicales.fr/author/Norisato%20Mitsutake",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University."
}
},
{
"@type": "Person",
"name": "Gabriele Hierlmeier",
"url": "https://questionsmedicales.fr/author/Gabriele%20Hierlmeier",
"affiliation": {
"@type": "Organization",
"name": "Universität Regensburg, Institut für Anorganische Chemie, 93040, Regensburg, Germany."
}
},
{
"@type": "Person",
"name": "Robert Wolf",
"url": "https://questionsmedicales.fr/author/Robert%20Wolf",
"affiliation": {
"@type": "Organization",
"name": "Universität Regensburg, Institut für Anorganische Chemie, 93040, Regensburg, Germany."
}
},
{
"@type": "Person",
"name": "Chibo Hong",
"url": "https://questionsmedicales.fr/author/Chibo%20Hong",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurological Surgery, University of California, San Francisco, California, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Antioxidant and anti-inflammatory function of Eupatorium adenophora Spreng leaves (EASL) on human intestinal Caco-2 cells treated with tert-butyl hydroperoxide.",
"datePublished": "2024-05-07",
"url": "https://questionsmedicales.fr/article/38714697",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-61012-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tert-butylhydroquinone and tert-butylcatechol positivity as warning lights of skin sensitization to tert-butylphenol derivatives in adhesives and diabetes devices.",
"datePublished": "2024-08-21",
"url": "https://questionsmedicales.fr/article/39168925",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cod.14670"
}
},
{
"@type": "ScholarlyArticle",
"name": "TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer.",
"datePublished": "2024-08-03",
"url": "https://questionsmedicales.fr/article/39097722",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12935-024-03459-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of Tert methylation alleviates food allergy via regulating the Tert-IL10 signal pathway.",
"datePublished": "2024-07-22",
"url": "https://questionsmedicales.fr/article/39034374",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12026-024-09504-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.",
"datePublished": "2023-12-23",
"url": "https://questionsmedicales.fr/article/38141254",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/neuonc/noad231"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Radicaux libres",
"item": "https://questionsmedicales.fr/mesh/D005609"
},
{
"@type": "ListItem",
"position": 4,
"name": "Peroxydes",
"item": "https://questionsmedicales.fr/mesh/D010545"
},
{
"@type": "ListItem",
"position": 5,
"name": "2-Hydroperoxy-2-méthyl-propane",
"item": "https://questionsmedicales.fr/mesh/D020122"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : 2-Hydroperoxy-2-méthyl-propane - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur 2-Hydroperoxy-2-méthyl-propane",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur 2-Hydroperoxy-2-méthyl-propane",
"description": "Comment diagnostiquer une exposition au tert-Butylhydroperoxide ?\nQuels tests sont utilisés pour évaluer la toxicité ?\nQuels symptômes indiquent une intoxication ?\nY a-t-il des marqueurs biologiques spécifiques ?\nComment évaluer les effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D020122#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur 2-Hydroperoxy-2-méthyl-propane",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nPeut-on avoir des symptômes neurologiques ?\nQuels signes indiquent une réaction allergique ?\nLes symptômes varient-ils selon la dose ?\nY a-t-il des symptômes spécifiques aux voies respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D020122#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur 2-Hydroperoxy-2-méthyl-propane",
"description": "Comment prévenir l'exposition au tert-Butylhydroperoxide ?\nQuelles formations sont nécessaires pour les travailleurs ?\nY a-t-il des réglementations spécifiques à suivre ?\nComment gérer les déversements accidentels ?\nLes zones de travail doivent-elles être ventilées ?",
"url": "https://questionsmedicales.fr/mesh/D020122#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur 2-Hydroperoxy-2-méthyl-propane",
"description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes existent-ils pour cette substance ?\nComment traiter les brûlures cutanées causées par ce produit ?\nQuel suivi médical est recommandé après exposition ?\nLes soins d'urgence sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D020122#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur 2-Hydroperoxy-2-méthyl-propane",
"description": "Quelles complications peuvent survenir après exposition ?\nY a-t-il des risques de cancer associés ?\nComment l'exposition affecte-t-elle le foie ?\nLes effets sur la reproduction sont-ils documentés ?\nDes troubles respiratoires peuvent-ils persister ?",
"url": "https://questionsmedicales.fr/mesh/D020122#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur 2-Hydroperoxy-2-méthyl-propane",
"description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il la sensibilité à la toxicité ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes femmes enceintes sont-elles plus vulnérables ?\nLes conditions environnementales affectent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D020122#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition au tert-Butylhydroperoxide ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests de laboratoire pour détecter des métabolites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la toxicité ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires peuvent être effectués pour mesurer les niveaux de toxines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme les enzymes hépatiques peuvent indiquer une atteinte hépatique."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets à long terme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des évaluations fonctionnelles peuvent aider à surveiller les effets chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent irritation des yeux, de la peau et des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des maux de tête et des étourdissements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une réaction allergique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, démangeaisons et gonflements peuvent signaler une allergie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux voies respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, toux, essoufflement et irritation de la gorge sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition au tert-Butylhydroperoxide ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles formations sont nécessaires pour les travailleurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations sur la manipulation sécurisée des produits chimiques sont essentielles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des réglementations spécifiques à suivre ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations sur le stockage et l'utilisation des produits chimiques doivent être respectées."
}
},
{
"@type": "Question",
"name": "Comment gérer les déversements accidentels ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des kits de déversement et suivre les procédures d'urgence établies."
}
},
{
"@type": "Question",
"name": "Les zones de travail doivent-elles être ventilées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne ventilation est cruciale pour réduire les risques d'exposition."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à retirer la personne de l'exposition et à administrer des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour cette substance ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les brûlures cutanées causées par ce produit ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rincer immédiatement à l'eau et appliquer des crèmes apaisantes si nécessaire."
}
},
{
"@type": "Question",
"name": "Quel suivi médical est recommandé après exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est conseillé pour surveiller d'éventuels effets à long terme."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas de symptômes graves, des soins d'urgence sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications hépatiques et pulmonaires peuvent se développer après une exposition prolongée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment l'exposition affecte-t-elle le foie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition peut entraîner une hépatotoxicité, avec des lésions hépatiques possibles."
}
},
{
"@type": "Question",
"name": "Les effets sur la reproduction sont-ils documentés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent des effets néfastes possibles sur la reproduction, mais les données sont limitées."
}
},
{
"@type": "Question",
"name": "Des troubles respiratoires peuvent-ils persister ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles respiratoires chroniques peuvent survenir après une exposition aiguë."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et ceux manipulant des agents oxydants sont à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité à la toxicité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies hépatiques ou respiratoires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes peuvent être plus vulnérables aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales affectent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme la chaleur ou l'humidité peuvent augmenter le risque d'exposition."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 29/06/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
3 publications dans cette catégorie
Affiliations :
Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University.
Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
3 publications dans cette catégorie
Affiliations :
Universität Regensburg, Institut für Anorganische Chemie, 93040, Regensburg, Germany.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
3 publications dans cette catégorie
Affiliations :
Universität Regensburg, Institut für Anorganische Chemie, 93040, Regensburg, Germany.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Department of Neurological Surgery, University of California, San Francisco, California, USA.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Department of Neurological Surgery, University of California, San Francisco, California, USA.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Program in Genetics and Genome Biology, and.
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Program in Genetics and Genome Biology, and.
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Program in Genetics and Genome Biology, and.
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Program in Genetics and Genome Biology, and.
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Department of Surgical Oncology, Graduate School of Biomedical Sciences, Nagasaki University.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
2 publications dans cette catégorie
Affiliations :
Institut für Anorganische Chemie, Universität Regensburg, 93040, Regensburg, Germany.
present address: Laboratory of Inorganic Chemistry, ETH Zürich, 8093, Zürich, Switzerland.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
1 publication dans cette catégorie
Affiliations :
BK21plus Glocal Education Program of Nutraceuticals Development, Konkuk University, Chungju, Republic of Korea.
Medicinal Biological Resources Research Institute, Konkuk University, Chungju, Republic of Korea.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
1 publication dans cette catégorie
Affiliations :
Division of Food Bio Science, Konkuk University, Chungju, Republic of Korea.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
1 publication dans cette catégorie
Affiliations :
Department of Applied Life Science, Konkuk University, Chungju, Republic of Korea.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
1 publication dans cette catégorie
Affiliations :
Department of Applied Life Science, Konkuk University, Chungju, Republic of Korea.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
1 publication dans cette catégorie
Affiliations :
Department of Applied Life Science, Konkuk University, Chungju, Republic of Korea.
Publications dans "2-Hydroperoxy-2-méthyl-propane" :
Chronic non-communicable diseases (CNCDs) pose a significant public health challenge. Addressing this issue, there has been a notable breakthrough in the prevention and mitigation of NCDs through the ...
Tert-butylphenol (TBP) derivatives, antioxidants in adhesives and diabetes devices, may provoke allergic contact dermatitis (ACD)....
The objective of this study is to report sensitization to TBP derivatives in medical devices and to highlight that tert-butylhydroquinone (BHQ) and tert-butylcatechol (TBC) are potential screeners in ...
Fifteen patients with ACD from adhesives and diabetes devices were patch tested to different TBPs: BHQ 1% pet., TBC 0.25% pet., BHA 2% pet., BHT 2% pet., 4-tert-butylphenol (TBP) 1% pet. and 2,4-di-te...
BHQ (9/13), TBC (7/13), and to a lesser extent BHT (3/15), BHA (2/15) and TBP (2/13) gave positive reactions. Seven patients had developed ACD from adhesives and diabetes devices, respectively, and on...
TBPs might be overlooked sensitizers in medical devices, and BHQ and TBC are potential screeners in this regard....
DNA hypermethylation and hotspot mutations were frequently observed in the upstream and core promoter of telomerase reverse transcriptase (TERT), respectively, and they were associated with increased ...
DNA demethylating agents 5-azacytidine and decitabine and a genomic locus-specific demethylation system based on dCas9-TET1 were used to assess the effects of TERT upstream promoter methylation on TER...
The level of DNA methylation at TERT upstream promoter and expression of TERT were significantly decreased after treatment with 5-azacytidine or decitabine in TERT promoter wild-type thyroid cancer ce...
This study uncovered the mechanism of promoter methylation mediated TERT activation in TERT promoter mutation-negative thyroid cancer cells and indicated TERT upstream promoter methylation as a therap...
The cause of food allergy (FA) is still a mystery. Telomerases are involved in the regulation of immune responses. This study aims to gain an understanding of the contribution of telomerase reverse tr...
A murine FA model was established with ovalbumin as the specific antigen. The role of TERT in regulating dendritic cell (DC) immune tolerogenic functions was evaluated in this murine model....
We observed that the Tert promoter was at demethylation status and the Tert expression was elevated in DCs of FA mice. The Tert expression in DCs had a positive correlation with the FA response. TERT ...
Low levels of Il10 expression and high levels of Tert expression were observed in intestinal DCs of FA mice. CpG exposure restored the expression of Il10 and increased the therapeutic benefits of alle...
The TERT promoter mutation (TPM) is acquired in most IDH-wildtype glioblastomas (GBM) and IDH-mutant oligodendrogliomas (OD) enabling tumor cell immortality. Previous studies on TPM clonality show con...
We investigated TPM clonality in relation to presumed early events in 19 IDH-wildtype GBM and 10 IDH-mutant OD using three-dimensional comprehensive tumor sampling. We performed Sanger sequencing on 2...
We detected TPM in 100% of tumor samples with quantifiable tumor purity (219 samples). Variant allele frequencies (VAF) of TPM correlate positively with chromosome 10 loss in GBM (R = 0.85), IDH1 muta...
On a tumor-wide scale, TPM is among the earliest events in glioma evolution. Intercellular heterogeneity of TERT expression, however, suggests dynamic regulation during tumor growth. TERT expression m...
Telomerase reverse transcriptase promoter (TERT-p) mutations, which upregulate TERT expression, are strongly associated with tumor aggressiveness and worse prognosis in papillary thyroid carcinomas (P...
TERT has multiple splicing variants whose relationships with the TERT-p status and clinicopathological characteristics remain poorly understood. We examined the relationship between the TERT-p mutatio...
We investigated the expression of two major variants, α deletion (dA) and β deletion (dB), in a series of 207 PTCs operated between November 2001 and March 2020 in Nagasaki University Hospital and Kum...
The TERT-p mutations were found in 33 cases, and among 174 mutation-negative cases, 24 showed TERT expression. All cases were classified into three groups: the TERT-p mutation-negative/expression-nega...
These results provide evidence that the TERT-p mutations alter the expression of different TERT splice variants, which, in turn, associates with different tumor aggressiveness....
Telomerase activity plays a crucial role in cancer development and progression. Thus, telomerase activation through the interplay of mutations and epigenetic alterations in the telomerase reverse tran...
In this study 100 bladder tumour tissues were selected, and four molecular signatures were analysed: THOR methylation status, TERT promotor mutation, telomere length, and TERT expression....
In our study, 88% of bladder cancer patients had an hypermethylation of the THOR region and 60% had mutations in the TERT promoter region. TERT promoter methylation was observed in all stages and grad...
The methylation and mutations occurring in the TERT promoter are implicated in bladder carcinogenesis, offering added prognostic and supplying novel insight into telomere biology in cancer....
Abnormal activation of telomerase occurs in most cancer types, which facilitates escaping from cell senescence. As the key component of telomerase, telomerase reverse transcriptase (TERT) is regulated...
Telomerase is intimately associated with stem cells and cancer, because it catalytically elongates telomeres-nucleoprotein caps that protect chromosome ends...
Sarcoidosis is a systemic inflammatory disease of unknown cause, characterized by the presence of non-caseating granulomas, which can affect all organs in the body, especially the lung. The fibrotic s...
A total of 93 patients, including 18 males and 73 females, who were clinically and histopathologically diagnosed with sarcoidosis were included in the study. The 78 patients included in the study were...
When non-fibrotic and fibrotic sarcoidosis groups were compared, no significant difference was found in terms of genotypes (p=0.76). The FEV1 (forced expiratory volume in the first second) % of the CC...
In sarcoidosis patients, telomerase rs2853669 polymorphism does not indicate progression to fibrosis, but since FEV1% was found to be lower in individuals with homozygous CC polymorphism, it is though...